Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study
Authors
Keywords
-
Journal
Gastroenterology Research and Practice
Volume 2017, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2017-02-22
DOI
10.1155/2017/4596176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- (2016) Claramae Shulyn Chia et al. ANNALS OF SURGICAL ONCOLOGY
- Impact of Major Complications on Patients’ Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- (2016) Trevor D. Hamilton et al. ANNALS OF SURGICAL ONCOLOGY
- Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis
- (2016) C. Demtröder et al. Colorectal Disease
- Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis
- (2016) Manuela Robella et al. World Journal of Surgical Oncology
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
- (2016) Ramy Girshally et al. World Journal of Surgical Oncology
- Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
- (2015) K. Odendahl et al. EJSO
- Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study
- (2015) Clemens B. Tempfer et al. GYNECOLOGIC ONCOLOGY
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis
- (2015) Giorgi Nadiradze et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
- (2015) Holly G. Prigerson et al. JAMA Oncology
- European reference values for the quality of life questionnaire EORTC QLQ-C30: Results of a German investigation and a summarizing analysis of six European general population normative studies
- (2014) Andreas Hinz et al. ACTA ONCOLOGICA
- Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study
- (2014) A. A. Wright et al. BMJ-British Medical Journal
- Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy
- (2013) Wiebke Solass et al. ANNALS OF SURGICAL ONCOLOGY
- Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
- (2013) Ana Blanco et al. ANNALS OF SURGICAL ONCOLOGY
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects
- (2013) Wiebke Solaß et al. ANNALS OF SURGICAL ONCOLOGY
- Description of a novel approach for intraperitoneal drug delivery and the related device
- (2012) Wiebke Solaß et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy
- (2011) Y. L. B. Klaver et al. ANNALS OF ONCOLOGY
- Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study
- (2010) Valery E. Lemmens et al. INTERNATIONAL JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started